Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.

Breda A, Konijeti R, Lam JS.

Expert Rev Anticancer Ther. 2007 Jun;7(6):847-62. Review.

PMID:
17555395
[PubMed - indexed for MEDLINE]
2.

Surveillance following radical or partial nephrectomy for renal cell carcinoma.

Lam JS, Leppert JT, Figlin RA, Belldegrun AS.

Curr Urol Rep. 2005 Feb;6(1):7-18. Review.

PMID:
15610692
[PubMed - indexed for MEDLINE]
3.

Novel approaches in the therapy of metastatic renal cell carcinoma.

Lam JS, Leppert JT, Belldegrun AS, Figlin RA.

World J Urol. 2005 Jul;23(3):202-12. Epub 2005 Apr 5. Review.

PMID:
15812574
[PubMed - indexed for MEDLINE]
4.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
5.

Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.

Lam JS, Belldegrun AS, Figlin RA.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6304S-9S. Review.

PMID:
15448022
[PubMed - indexed for MEDLINE]
Free Article
6.

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS.

J Urol. 2005 Aug;174(2):466-72; discussion 472; quiz 801.

PMID:
16006866
[PubMed - indexed for MEDLINE]
7.

Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.

Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML.

BJU Int. 2009 Sep;104(6):778-85. doi: 10.1111/j.1464-410X.2009.08499.x. Epub 2009 Mar 11.

PMID:
19338559
[PubMed - indexed for MEDLINE]
8.

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.

Lam JS, Leppert JT, Figlin RA, Belldegrun AS.

Urology. 2005 Nov;66(5 Suppl):1-9. Review.

PMID:
16194700
[PubMed - indexed for MEDLINE]
9.

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Janzen NK, Kim HL, Figlin RA, Belldegrun AS.

Urol Clin North Am. 2003 Nov;30(4):843-52. Review.

PMID:
14680319
[PubMed - indexed for MEDLINE]
10.

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS.

J Urol. 2005 Jun;173(6):1853-62. Review.

PMID:
15879764
[PubMed - indexed for MEDLINE]
11.

Advances and controversies in grading and staging of renal cell carcinoma.

Delahunt B.

Mod Pathol. 2009 Jun;22 Suppl 2:S24-36. doi: 10.1038/modpathol.2008.183. Review.

PMID:
19494851
[PubMed - indexed for MEDLINE]
Free Article
12.

Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.

Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.

BJU Int. 2009 Aug;104(4):461-9. doi: 10.1111/j.1464-410X.2009.08489.x. Epub 2009 Mar 11.

PMID:
19338563
[PubMed - indexed for MEDLINE]
13.

Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.

Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG.

Cancer. 2008 Apr 1;112(7):1480-8. doi: 10.1002/cncr.23322.

PMID:
18240184
[PubMed - indexed for MEDLINE]
Free Article
14.

Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.

Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CG.

J Urol. 2009 May;181(5):2044-51. doi: 10.1016/j.juro.2009.01.043. Epub 2009 Mar 14.

PMID:
19286220
[PubMed - indexed for MEDLINE]
15.

Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML.

J Urol. 2008 Jul;180(1):99-103; discussion 103. doi: 10.1016/j.juro.2008.03.025. Epub 2008 May 15.

PMID:
18485415
[PubMed - indexed for MEDLINE]
16.

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.

Lam JS, Breda A, Belldegrun AS, Figlin RA.

J Clin Oncol. 2006 Dec 10;24(35):5565-75. Review.

PMID:
17158542
[PubMed - indexed for MEDLINE]
17.

Prognostic factors in renal cell carcinoma.

Shuch BM, Lam JS, Belldegrun AS, Figlin RA.

Semin Oncol. 2006 Oct;33(5):563-75. Review.

PMID:
17045085
[PubMed - indexed for MEDLINE]
18.

Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.

Geller JI, Argani P, Adeniran A, Hampton E, De Marzo A, Hicks J, Collins MH.

Cancer. 2008 Apr 1;112(7):1607-16. doi: 10.1002/cncr.23331.

PMID:
18278810
[PubMed - indexed for MEDLINE]
Free Article
19.

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.

Eichelberg C, Junker K, Ljungberg B, Moch H.

Eur Urol. 2009 Apr;55(4):851-63. doi: 10.1016/j.eururo.2009.01.003. Epub 2009 Jan 13. Review.

PMID:
19155123
[PubMed - indexed for MEDLINE]
20.

Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.

Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.

Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.

PMID:
18692951
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk